Cargando…

Attenuated measles virus as a vaccine vector

Live attenuated measles virus (MV) vaccines have an impressive record of safety, efficacy and ability to induce life-long immunity against measles infection. Using reverse genetics technology, such negative-strand RNA viruses can now be rescued from cloned DNA. This technology allows the insertion o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuniga, Armando, Wang, ZiLi, Liniger, Matthias, Hangartner, Lars, Caballero, Michael, Pavlovic, Jovan, Wild, Peter, Viret, Jean Francois, Glueck, Reinhard, Billeter, Martin A., Naim, Hussein Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707277/ https://www.ncbi.nlm.nih.gov/pubmed/17303293 http://dx.doi.org/10.1016/j.vaccine.2007.01.064

Ejemplares similares

Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses
por: Liniger, Matthias, et al.
Publicado: (2009)

Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses
por: Liniger, Matthias, et al.
Publicado: (2008)

Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009)

Immunogenicity of next-generation HPV vaccines in non-human primates: Measles-vectored HPV vaccine versus Pichia pastoris recombinant protein vaccine
por: Gupta, Gaurav, et al.
Publicado: (2016)

Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination
por: Baldo, Aline, et al.
Publicado: (2015)

The Prevention and Attenuation of Measles
por: Allison, V. D.
Publicado: (1933)

Measles virus gene expression in subacute sclerosing panencephalitis
por: Baczko, Knut, et al.
Publicado: (1984)

Wild type measles virus attenuation independent of type I IFN
por: Druelle, Johan, et al.
Publicado: (2008)

Antitumor Virotherapy by Attenuated Measles Virus (MV)
por: Guillerme, Jean-Baptiste, et al.
Publicado: (2013)

Autophagy in Measles Virus Infection
por: Rozières, Aurore, et al.
Publicado: (2017)

Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates
por: Bolton, Diane L., et al.
Publicado: (2012)

Restriction of measles virus gene expression in acute and subacute encephalitis of Lewis rats
por: Schneider-Schaulies, Sibylle, et al.
Publicado: (1989)

Biased hypermutation and other genetic changes in defective measles viruses in human brain infections
por: Cattaneo, Roberto, et al.
Publicado: (1988)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Suspected and Confirmed Vector-Borne Rickettsioses of North America Associated with Human Diseases
por: Hardstone Yoshimizu, Melissa, et al.
Publicado: (2018)

Measles or Not Measles? That Is the Question!
por: Ibraheim, Marina Kristy, et al.
Publicado: (2020)

Natural Oncolytic Activity of Live-Attenuated Measles Virus against Human Lung and Colorectal Adenocarcinomas
por: Boisgerault, Nicolas, et al.
Publicado: (2013)

Measles Virus Glycoprotein-Based Lentiviral Targeting Vectors That Avoid Neutralizing Antibodies
por: Kneissl, Sabrina, et al.
Publicado: (2012)

Immunogenicity and Efficacy of a Measles Virus-Vectored Chikungunya Vaccine in Nonhuman Primates
por: Rossi, Shannan L, et al.
Publicado: (2019)

Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
por: Ebenig, Aileen, et al.
Publicado: (2022)

Viral vectors for malaria vaccine development
por: Li, Shengqiang, et al.
Publicado: (2007)

Distinct Contributions of Autophagy Receptors in Measles Virus Replication
por: Petkova, Denitsa S., et al.
Publicado: (2017)

Development of measles virus-based shielded oncolytic vectors: suitability of other paramyxovirus glycoproteins
por: Hudacek, Andrew W., et al.
Publicado: (2013)

Eradication of measles: remaining challenges
por: Holzmann, Heidemarie, et al.
Publicado: (2016)

Measles
Publicado: (1905)

Measles
Publicado: (1889)

Measles
por: Qi, Shi, et al.
Publicado: (2015)

Measles
por: Moss, William J., et al.
Publicado: (2009)

Measles
Publicado: (1878)

Measles
Publicado: (1859)

Measles
Publicado: (1884)

Measles
Publicado: (1883)

Measles
Publicado: (1889)

Interplay between Virus-Specific Effector Response and Foxp3(+) Regulatory T Cells in Measles Virus Immunopathogenesis
por: Sellin, Caroline I., et al.
Publicado: (2009)

Antibodies against viruses: passive and active immunization
por: Law, Mansun, et al.
Publicado: (2008)

MDA5 Can Be Exploited as Efficacious Genetic Adjuvant for DNA Vaccination against Lethal H5N1 Influenza Virus Infection in Chickens
por: Liniger, Matthias, et al.
Publicado: (2012)

Live Attenuated Measles Virus Vaccine Expressing Helicobacterpylori Heat Shock Protein A
por: Iankov, Ianko D., et al.
Publicado: (2020)

STUDIES ON MEASLES : I. SUSCEPTIBILITY OF MONKEYS TO THE VIRUS OF MEASLES.
por: Blake, Francis G., et al.
Publicado: (1921)

Measles to the Rescue: A Review of Oncolytic Measles Virus
por: Aref, Sarah, et al.
Publicado: (2016)

Global Transmission Dynamics of Measles in the Measles Elimination Era
por: Furuse, Yuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_81jpon7qvugskg07ccac39fbk8